Los Angeles, CALIFORNIA4 Active Studies

Primary Biliary Cholangitis Clinical Trials in Los Angeles, CALIFORNIA

Find 4 actively recruiting primary biliary cholangitis clinical trials in Los Angeles, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,004
Enrolling

Recruiting Primary Biliary Cholangitis Studies in Los Angeles

About Primary Biliary Cholangitis Clinical Trials in Los Angeles

Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease in which the bile ducts in the liver are slowly destroyed. This leads to bile buildup, liver damage, and potentially cirrhosis. Treatment includes ursodeoxycholic acid and obeticholic acid.

There are currently 4 primary biliary cholangitis clinical trials recruiting participants in Los Angeles, CALIFORNIA. These studies are seeking a combined 1,004 participants. Research is being sponsored by Gilead Sciences, Ipsen, Mirum Pharmaceuticals, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Primary Biliary Cholangitis Clinical Trials in Los Angeles — FAQ

Are there primary biliary cholangitis clinical trials in Los Angeles?

Yes, there are 4 primary biliary cholangitis clinical trials currently recruiting in Los Angeles, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What primary biliary cholangitis treatments are being tested?

The 4 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for primary biliary cholangitis.

Data updated March 2, 2026 from ClinicalTrials.gov